Skip to main content
OpenTrials

Clinical trial condition

Esophageal Diseases

Explore clinical trials studying Esophageal Diseases. Study availability and eligibility vary by location and protocol.

3,519 public trials 714 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Diseases trial results

Active, Not Recruiting

Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.

NCT05267613

Conditions
Deglutition Disorders, Digestive System Diseases, Erosive Esophagitis, +4 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Sacramento, California, United States
  • Research Site Miami, Florida, United States
  • Research Site Miami, Florida, United States
View all 41 locations
View Trial Details
Active, Not Recruiting

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

NCT06781983

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Diseases, +64 more
Locations
  • Massachusetts General Hospital - Boston Boston, Massachusetts, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
  • Mount Sinai Tisch Cancer Center New York, United States
  • NEXT Oncology - Dallas Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy

NCT04543617

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations
  • Florida Cancer Specialists - Fort Myers (Broadway) Fort Myers, Florida, United States
  • Cancer Center of Kansas Wichita, Kansas, United States
  • Great Lakes Cancer Center Williamsville, New York, United States
  • Instituto de Investigaciones Metabolicas (Idim) Buenos Aires, Argentina
View all 167 locations
View Trial Details
Active, Not Recruiting

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

NCT06607185

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT05078047

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
Locations
  • Institut de cancérologie de l'Ouest Angers, France
  • Clinique Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • CHU Bordeaux - Hôpial Saint André Bordeaux, France
View all 33 locations
View Trial Details
Active, Not Recruiting

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

NCT05152147

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • Hospital de Gastroenterología Dr Bonorino Udaondo Buenos Aires, Argentina
  • Instituto de Investigaciones Metabólicas - IDIM Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires Buenos Aires, Argentina
  • Fundación Centro de Medicina Nuclear y Molecular ER Córdoba, Argentina
View all 227 locations
View Trial Details

Related conditions